login
Current Deals

company details

MARTIN AND HARRIS LABORATORIES LIMITED

  • martinharrislabs.com
  • Sector: Healthcare
  • CHRYSEUM SCORE: 9.00/10.00
    ×

    MARTIN AND HARRIS LABORATORIES LIMITED

    • Sector: Healthcare
    • CHRYSEUM SCORE: 9.00/10.00

    Description: Martin & Harris Laboratories Ltd is engaged in the manufacturing of Pharmaceutical, medicinal chemical & botanical products.

    Evaluation is basis the latest financial year disclosures filed by the company

    Valuation

    Max Score: 3.50

    P/E of Company

    5.43

    AVG P/E of Key Peer/s

    98.71

    Valuation Score

    3.50

    The Valuation Score depicts if the company is available at a discount when compared to its listed/unlisted peers. Higher the discount, more is the score given to the company.

    Growth

    Max Score: 3.50

    Sales Growth

    -8.44%

    PAT Growth

    74.87%

    ROE

    11.47%

    Growth Score

    2.50

    The Growth Score accounts for the growth in Sales and PAT on a 3 year CAGR basis and the Company’s ROE as per the latest financial year results released by the company.

    Leverage

    Max Score: 1.50

    Debt / Equity

    0.01

    AVG Industry Debt / Equity

    0.30

    Leverage Score

    3.00

    Lower the Debt/Equity, higher the score.

    Management Quality

    Max Score: 1.50

    Board Structure & Composition

    1.00

    Related Party Transactions

    1.00

    Timely Disclosure

    1.00

    Management Score

    1.50

    This score represents a consolidated view of the Company’s Management Quality, which includes Board Structure, Related Party Transactions and Timely disclosures. Each parameter is scored out of 1.

₹910.00 0.00 (0.00%)

As on 13 Sep, 2024
L 875.00 52 Week Range H 1200.00
Company Description : It is engaged in the manufacturing of Pharmaceutical, medicinal chemical & botanical products. It is part of the Apeejay Group, which is India's oldest and largest conglomerate
Company Overview
  • Name of Company MARTIN AND HARRIS LABORATORIES LIMITED
  • Sector Healthcare
  • ISIN INE03VV01015
  • Scrip Code MARTIN & HARRIS
  • CIN U24239HR1993PLC033630
  • Pan No AABCM0832A
  • Face Value 10
  • Price ₹ 910.00
  • No. of Shares outstanding 0.40 Cr.
  • Market Cap ₹ 363.64 Cr
Financials
  • Revenue from operations ₹ 146.15 Cr.
  • EBITDA ₹ 60.44 Cr.
  • EBITDA Margin % 41.35%
  • Profit After Tax ₹ 40.44 Cr.
  • PAT Margin % 22.41%
  • EPS 101.20
  • Stock P/E 8.99
  • Book Value Per Share 1,581.74
  • P/B 0.58
  • Debt/Equity 0.01
Other Key Statistics
  • 52 week High/Low 1200.00/875.00
  • Dividend Per Share 1.80
  • Dividend Yield 0.00
  • Sales Growth - 3 years -4.48%
  • EBITDA Growth - 3 years -5.66%
  • PAT Growth - 3 years -7.50%
  • EPS Growth - 3 years -7.50%
  • ROE 6.40%
  • ROCE 8.82%
  • Cash Equivalents 44.37
All figures below are in INR Crores unless otherwise stated

Peer Comparison

Key Financials - FY24
Company Name Martin & Harris Neuland Laboratories Ltd
Listing Status Unlisted Listed
Revenue from Operations 146.15 1,558.58
Total Income 180.44 1,571.12
Finance Cost 0.58 14.00
Depreciation & Amortization 4.63 59.70
Total Expenses 125.21 1,169.69
EBITDA 60.44 475.13
PAT 40.44 300.08
No. of Shares Outstanding 0.40 1.28
EPS (in ₹) 101.20 233.89
Share Capital 4.00 12.90
Total Net Worth 632.07 1,282.70
Total Assets 661.97 1,832.56
Total Debt 7.83 82.51
Key Metrics:
CMP* 910.00 12,771.10
Market Cap (In Cr.) 363.64 16,347.01
Market Cap/Sales 2.02 10.40
EPS (Earnings Per Share) 101.20 233.89
BVPS (Book Value Per Share) 1,581.74 999.77
P/E 8.99 54.60
P/BV 0.58 12.77
EBITDA Margin 41.35% 30.48%
ROE 6.40% 23.39%
ROA 6.11% 16.37%
*Market Price in ₹ as on 13 Sep, 2024

Profit Loss

FY24 FY23 FY22 FY21 FY20
Revenue from operations 146.15 205.16 186.31 167.68 267.29
Y-o-Y Revenue Growth -28.76% 10.12% 11.11% -37.27% 8.11%
Other Income 34.29 24.08 25.79 12.30 29.43
Total Income 180.44 229.24 212.10 179.98 296.72
Total Expenses (Excludes Interest and Depreciation) 120.00 133.01 115.07 107.99 270.74
Operating Profit (After deducting Depreciation) 21.52 68.22 67.79 56.46 -5.76
OPM % 14.72 33.25 36.39 33.67 -2.15
EBITDA 60.44 96.23 97.03 71.99 25.98
Depreciation 4.63 3.93 3.45 3.23 2.31
EBIT 55.81 92.30 93.58 68.76 23.67
Interest 0.58 0.22 0.16 0.24 0.25
EBT before Exceptional Items 55.23 92.08 93.42 68.52 23.42
Prior period/Exceptional /Extra Ordinary Items 0.00 0.00 0.00 0.00 0.00
Profit before tax/EBT 55.23 92.08 93.42 68.52 23.42
Tax 14.79 24.02 23.26 17.42 10.69
Net Profit 40.44 68.06 70.16 51.10 12.73
Profit (loss) of minority interest 0.00 0.00 0.00 0.00 0.00
Total profit (loss) for period 40.44 68.06 70.16 51.10 12.73
EPS in Rs 101.20 170.32 175.57 127.88 31.85
EPS Change % -40.58% -2.99% 37.30% 301.50% -82.43%
EBITDA Change % -37.19% -0.82% 34.78% 177.10% -72.29%
Profit growth -40.58% -2.99% 37.30% 301.41% -82.42%
ROCE 8.82% 15.53% 17.71% 15.41% 8.75%
ROE 6.40% 11.47% 13.30% 11.47% 4.73%
Debt / Equity Ratio 0.01 0.01 0.01 0.01 0.05
Sales growth 3Years -4.48% -8.44%
Sales growth 5Years -9.98% 4.26%
Dividend per share 1.80 5.20

Balance Sheet

FY24 FY23 FY22 FY21 FY20
Share Capital 4.00 4.00 4.00 4.00 4.00
Reserves 628.07 589.29 523.33 441.62 265.13
Total shareholders' funds 632.07 593.29 527.33 445.62 269.13
Borrowings 7.83 4.19 3.94 4.55 13.09
Other Liabilities 4.18 6.16 3.32 4.42 14.69
Total Liabilities 29.90 21.38 15.24 14.90 39.30
Fixed Assets 17.76 15.53 51.08 53.49 50.55
Capital WIP 0.00 3.41 0.40 0.00 2.80
Investments 34.17 24.63 334.67 72.05 189.93
Other Assets 497.83 481.12 107.52 213.93 12.80
Total Assets 661.97 614.66 542.56 460.51 308.43
Cash Equivalents 44.37 0.89 21.39 101.62 0.79
Total Current liability 29.17 20.30 14.02 14.20 37.99
Total Assets -Total Current liabilty 632.80 594.36 528.54 446.31 270.44

Cash Flow

FY24 FY23 FY22 FY21 FY20
Net Cash from / (used in) Operating Activity 19.57 -344.02 -152.19 -167.13 -22.50
Net Cash from / (used in) Investing Activity -21.22 325.44 -132.49 178.32 14.59
Net Cash from / (used in) Financing Activity 1.07 -1.94 0.68 -9.60 8.09
Net Inc/Dec In Cash And Cash Equivalents -0.58 -20.50 19.01 1.58 0.19

Share Holding Pattern

No. of Shares in Crs. % Holding
Promoters 0.00 0.00%
Non Promoters 0.40 100.00%

News

  • No news found.

© 2022 Chryseum Advisors LLP. All rights reserved. LLPIN – AAD-0626

+91 98925 31672 | info@chryseum.in

For latest updates

Linkedin-in